Current Report Filing (8-k)
December 10 2014 - 4:13PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
|
Date of Report (Date of Earliest Event Reported):
|
|
December 10, 2014
|
Health Net, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
|
1-12718
|
95-4288333
|
_____________________
(State or other jurisdiction
|
_____________
(Commission
|
______________
(I.R.S. Employer
|
of incorporation)
|
File Number)
|
Identification No.)
|
|
|
|
21650 Oxnard Street, Woodland Hills, California
|
|
91367
|
_________________________________
(Address of principal executive offices)
|
|
___________
(Zip Code)
|
|
|
|
Registrants telephone number, including area code:
|
|
(818) 676-6000
|
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01. Regulation FD Disclosure.
Members of the management team of Health Net, Inc. (the Company) expect to meet with
investors and analysts at the Bank of America Merrill Lynch 2014 Chicago Health Care One-on-One
Conference on December 11, 2014.
During these meetings, the Company intends to address its prospects and historical
performance, and reaffirm the Companys earnings guidance for the full year 2014, as previously
announced in a press release issued on November 3, 2014. In addition, during these meetings, the
Company intends to reaffirm its preliminary comments relating to full year 2015 performance, as
previously announced on the Companys third quarter earnings conference call on November 3, 2014. A
transcript of the Companys third quarter 2014 earnings conference call is available in the
Investor Relations Presentations and Webcasts Transcripts section of the Companys website at
www.healthnet.com.
The information in this Item 7.01 shall not be deemed filed for purposes of Section 18 of
the Securities Exchange Act of 1934 (the Exchange Act) or otherwise subject to the liabilities of
that section, nor shall it be deemed incorporated by reference in any Company filing under the
Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific
reference in such filing.
CAUTIONARY STATEMENTS: The Company and its representatives may from time to time make written and
oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act
(PSLRA) of 1995, including statements in this and other reports, in presentations, press
releases, filings with the Securities and Exchange Commission (SEC), and in meetings with
investors and analysts. All statements in this report, other than statements of historical
information provided herein, may be deemed to be forward-looking statements and as such are
intended to be covered by the safe harbor for forward-looking statements provided by PSLRA. These
statements are based on managements analysis, judgment, belief and expectation only as of the date
hereof, and are subject to changes in circumstances and a number of risks and uncertainties.
Without limiting the foregoing, statements including the words believes, anticipates, plans,
expects, may, should, could, estimate, intend, feels, will, projects and other
similar expressions are intended to identify forward-looking statements. Actual results could
differ materially from those expressed in, or implied or projected by the forward-looking
information and statements due to, among other things, health care reform and other increased
government participation in and taxation or regulation of health benefits and managed care
operations, including but not limited to the implementation of the Patient Protection and
Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the
ACA) and related fees, assessments and taxes; the Companys ability to successfully participate
in Californias Coordinated Care Initiative, which is subject to a number of risks inherent in
untested health care initiatives and requires the Company to adequately predict the costs of
providing benefits to individuals that are generally among the most chronically ill within each of
Medicare and Medi-Cal and implement delivery systems for benefits with which the Company has
limited operating experience; the Companys ability to successfully participate in the federal and
state health insurance exchanges under the ACA, which have experienced technical challenges in
implementation and which involve uncertainties related to the mix and volume of business that could
negatively impact the adequacy of the Companys premium rates and may not be sufficiently offset by
the risk apportionment provisions of the ACA; increasing health care costs, including but not
limited to costs associated with the introduction of new treatments or therapies; the Companys
ability to reduce administrative expenses while maintaining targeted levels of service and
operating performance, including through the Companys master services agreement with Cognizant;
whether the Company receives required regulatory approvals for Cognizants provision of services to
the Company and any conditions imposed in order to obtain such regulatory approvals; the Companys
ability to recognize the intended cost savings and other intended benefits of the Cognizant
transaction; and the risk that Cognizant may not perform contracted functions and services in a
timely, satisfactory and compliant manner; negative prior period claims reserve developments; rate
cuts and other risks and uncertainties affecting the Companys Medicare or Medicaid businesses; the
Companys ability to successfully participate in Arizonas Medicaid program; trends in medical care
ratios; membership declines or negative changes in the Companys health care product mix;
unexpected utilization patterns or unexpectedly severe or widespread illnesses; the timing of
collections on amounts receivable from state and federal governments and agencies, including
collections of amounts owed under the T-3 contract; litigation costs; regulatory issues with
federal and state agencies including, but not limited to, the California Department of Managed
Health Care, the Centers for Medicare & Medicaid Services, the Office of Civil Rights of the U.S.
Department of Health and Human Services and state departments of insurance; operational issues;
changes in economic or market conditions; failure to effectively oversee the Companys third-party
vendors; noncompliance by the Company or the Companys business associates with any privacy laws or
any security breach involving the misappropriation, loss or other unauthorized use or disclosure of
confidential information; impairment of the Companys goodwill or other intangible assets;
investment portfolio impairment charges; volatility in the financial markets; and general business
and market conditions. Additional factors that could cause actual results to differ materially from
those reflected in the forward-looking statements include, but are not limited to, the risks
discussed in the Risk Factors section included within the Companys most recent Annual Report on
Form 10-K and subsequent Quarterly Reports on Form 10-Q filed with the SEC and the other risks
discussed in the Companys filings with the SEC. Readers are cautioned not to place undue reliance
on these forward-looking statements. Except as may be required by law, the Company undertakes no
obligation to address or publicly update any forward-looking statements to reflect events or
circumstances that arise after the date of this report.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
Health Net, Inc. |
|
|
|
|
|
|
|
December 10, 2014
|
|
|
|
By:
|
|
/s/ James E. Woys |
|
|
|
|
|
|
|
|
|
|
|
Name:
|
|
James E. Woys |
|
|
|
|
Title:
|
|
Executive Vice President, Chief
Financial and Operating Officer and
Interim Treasurer |
Health Net (NYSE:HNT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Health Net (NYSE:HNT)
Historical Stock Chart
From Sep 2023 to Sep 2024